News

Anticalins are recombinantly engineered lipocalins, endogenous low-molecular weight human proteins that naturally bind, store and transport a wide spectrum of molecules. The tie up includes an option of

Earlier, on 23 September 2010, the FDA and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of

According to the pact, Akrimax Pharma got license from NovaDel Pharma for the manufacturing and commercialization of NitroMist in North America. NovaDel Pharma’s NitroMist (nitroglycerin sublingual spray) belongs

The achievement represents progress for the collaboration, which was launched in September 2010 to develop G protein coupled receptor (GPCR)-targeted therapeutic compounds utilizing Anchor’s proprietary pepducin technology. Pepducins

Revolutions Medical said that the capacity can be increased to 20 million syringes per month, and shipments will begin by July 2011. The agreement extends the company’s relationship

ASCENTA 4.0 integrates two generations of gene expression content on the Affymetrix platform into one easy-to-use application, the company said. It features enhancements such as Gene Ontology view

SOHM said that the promotion of Shah will be effective on 15 January 2011. Shah said that they are creating new opportunities for partnerships and joint ventures with

As part of the transaction, Bolh will join the AHS management team as senior vice president, bringing in more than 30 years of experience in clinical and management

The trial designed to get pharmacokinetics and pharmacodynamics as well as safety and efficacy data by demonstrating bioequivalence of the product. Sandoz said that the previous data suggested